These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22164203)

  • 1. Perspectives on the use of multiple sclerosis risk genes for prediction.
    Jafari N; Broer L; van Duijn CM; Janssens AC; Hintzen RQ
    PLoS One; 2011; 6(12):e26493. PubMed ID: 22164203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis.
    Hoppenbrouwers IA; Aulchenko YS; Janssens AC; Ramagopalan SV; Broer L; Kayser M; Ebers GC; Oostra BA; van Duijn CM; Hintzen RQ
    J Hum Genet; 2009 Nov; 54(11):676-80. PubMed ID: 19834503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk alleles for multiple sclerosis in multiplex families.
    D'Netto MJ; Ward H; Morrison KM; Ramagopalan SV; Dyment DA; DeLuca GC; Handunnetthi L; Sadovnick AD; Ebers GC
    Neurology; 2009 Jun; 72(23):1984-8. PubMed ID: 19506219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians.
    Rubio JP; Stankovich J; Field J; Tubridy N; Marriott M; Chapman C; Bahlo M; Perera D; Johnson LJ; Tait BD; Varney MD; Speed TP; Taylor BV; Foote SJ; Butzkueven H; Kilpatrick TJ
    Genes Immun; 2008 Oct; 9(7):624-30. PubMed ID: 18650830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of multiple sclerosis: an update 2010.
    Hoffjan S; Akkad DA
    Mol Cell Probes; 2010 Oct; 24(5):237-43. PubMed ID: 20450971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the established non-MHC multiple sclerosis loci in an Indian population.
    Pandit L; Ban M; Sawcer S; Singhal B; Nair S; Radhakrishnan K; Shetty R; Misri Z; Hegde S; Bhat IG
    Mult Scler; 2011 Feb; 17(2):139-43. PubMed ID: 20952449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GWAS-identified multiple sclerosis risk loci involved in immune response: validation in Russians.
    Bashinskaya VV; Kulakova OG; Kiselev IS; Baulina NM; Favorov AV; Boyko AN; Tsareva EY; Favorova OO
    J Neuroimmunol; 2015 May; 282():85-91. PubMed ID: 25903733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EVI5 is a risk gene for multiple sclerosis.
    Hoppenbrouwers IA; Aulchenko YS; Ebers GC; Ramagopalan SV; Oostra BA; van Duijn CM; Hintzen RQ
    Genes Immun; 2008 Jun; 9(4):334-7. PubMed ID: 18401352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No influence on disease progression of non-HLA susceptibility genes in MS.
    Lundström W; Greiner E; Lundmark F; Westerlind H; Smestad C; Lorentzen AR; Kockum I; Link J; Brynedal B; Celius EG; Harbo HF; Masterman T; Hillert J
    J Neuroimmunol; 2011 Aug; 237(1-2):98-100. PubMed ID: 21742385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of interleukin-10 gene promoter polymorphisms with HLA-DRB1*15 allele is associated with multiple sclerosis.
    Shahbazi M; Abadi JSA; Roshandel D; Koochaki M; Amiri H; Kohansal R; Baghbanian SM; Zamani M
    Indian J Med Res; 2017 Jun; 145(6):746-752. PubMed ID: 29067976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of HLA-DRB1 and HLA-DQB1 alleles with genetic susceptibility to multiple sclerosis in the Slovak population.
    Michalik J; Čierny D; Kantorová E; Kantárová D; Juraj J; Párnická Z; Kurča E; Dobrota D; Lehotský J
    Neurol Res; 2015; 37(12):1060-7. PubMed ID: 26744784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution melting curve analysis of polymorphisms within CD58, CD226, HLA-G genes and association with multiple sclerosis susceptibility in a subset of Iranian population: a case-control study.
    Ghavimi R; Alsahebfosoul F; Salehi R; Kazemi M; Etemadifar M; Zavaran Hosseini A
    Acta Neurol Belg; 2020 Jun; 120(3):645-652. PubMed ID: 30128676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
    J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.
    Shawkatová I; Javor J; Párnická Z; Bucová M; Čopíková-Cudráková D; Michalík J; Gmitterová K; Čierny D; Buc M; Ďurmanová V
    Folia Microbiol (Praha); 2017 Jul; 62(4):287-293. PubMed ID: 28130760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.
    Mero IL; Ban M; Lorentzen ÅR; Smestad C; Celius EG; Sæther H; Saeedi H; Viken MK; Skinningsrud B; Undlien DE; Aarseth J; Myhr KM; Granum S; Spurkland A; Sawcer S; Compston A; Lie BA; Harbo HF
    Genes Immun; 2011 Apr; 12(3):191-8. PubMed ID: 21179112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.
    Gourraud PA; McElroy JP; Caillier SJ; Johnson BA; Santaniello A; Hauser SL; Oksenberg JR
    Ann Neurol; 2011 Jan; 69(1):65-74. PubMed ID: 21280076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Multiple Sclerosis-Associated
    Buhelt S; Søndergaard HB; Oturai A; Ullum H; von Essen MR; Sellebjerg F
    Cells; 2019 Jun; 8(6):. PubMed ID: 31242590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication analysis of variants associated with multiple sclerosis risk.
    Dashti M; Ateyah K; Alroughani R; Al-Temaimi R
    Sci Rep; 2020 Apr; 10(1):7327. PubMed ID: 32355262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms.
    Fransen NL; Crusius JBA; Smolders J; Mizee MR; van Eden CG; Luchetti S; Remmerswaal EBM; Hamann J; Mason MRJ; Huitinga I
    Brain Pathol; 2020 Jan; 30(1):106-119. PubMed ID: 31228212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.